Antibacterial activities and modes of action of vancomycin and related glycopeptides.
about
Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?mMass as a software tool for the annotation of cyclic peptide tandem mass spectraRegulation of expression of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptideAnalysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci.Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocciCharacterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.Product quality of parenteral vancomycin products in the United States.The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.Cross-talk between the histidine protein kinase VanS and the response regulator PhoB. Characterization and identification of a VanS domain that inhibits activation of PhoB.Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.Site-specific C-functionalization of free-(NH) peptides and glycine derivatives via direct C-H bond functionalization.Peptides as the next generation of anti-infectives.The times they are a-changin': new antibacterials for skin and skin structure infections.Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis.Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.Genetics and mechanisms of glycopeptide resistance in enterococci.Teicoplanin or vancomycin in the treatment of gram-positive infections?Therapeutic drug monitoring of antimicrobials.Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier.Investigation of vancomycin and related substances by liquid chromatography/ion trap mass spectrometry.Amexanthomycins A-J, pentangular polyphenols produced by Amycolatopsis mediterranei S699∆rifA.[Problems with gram-positive bacteria: resistance in staphylococci, enterococci, and pneumococci to antimicrobial drugs]
P2860
Q24678550-26FF5C84-873C-4234-AB1C-33CF2EEAF36FQ28483744-646A4157-7329-4AF8-AB93-338AA2996F84Q34011872-F6EC94CF-F626-488A-8151-D88D2BCE7F65Q35044119-56D8745B-CC84-4C9A-88D8-F0057F470A49Q35138478-6A5FAB01-089A-46AA-9DD8-24766B90FDFBQ35808723-9235C4E2-4387-4E87-AFCD-D8A3B075B26AQ35815090-ECAF2C39-E967-46B1-A0D0-EBAB63CE79D4Q35846561-FA51BBC4-B04B-47E8-BFDA-06D7F5E29665Q35885570-5E9F857A-14CD-45DB-9DB1-8FEE8A8A82CEQ35965824-6EF219A2-04EA-4881-B6B2-4120944EA85EQ36018909-DE70DA55-71CF-462E-9C72-3B45265875FCQ36110967-D061BCD0-D896-4548-936B-8D53721C3F55Q36681707-2399CF70-EAC3-47FA-BC3F-9AE2E6CE8507Q37068218-4B7F27E2-96F9-445B-82EF-D545304A7643Q37112461-47A9AB7C-C8D9-4EFF-B241-F859590D4F98Q38086871-DF7F4C06-2402-4D51-84C6-ABFCDCEF3477Q38438503-BAD7922A-D0F6-43AD-99D4-DFCC00A6A2C9Q38503990-BD6ED551-D624-4185-A11A-D29DBED8464FQ39326133-7301842F-5F1E-4B71-AC32-C0F6989C8D03Q39866365-E5A9B2DD-2527-4ED8-BC16-10E0AB51F9A0Q40541603-86C6F515-F527-4F16-ACE9-681DD6E9F726Q40915627-17FF937D-0FD1-4CBE-95FE-621329CD4CF2Q41066696-2ED832BB-F81F-4A11-9B23-7F13E8DDCE5BQ41980687-F2C1012A-D6BF-4E44-BBD8-4E8D5517660BQ44787711-F937FA61-F3B7-4901-832F-9B3CC91F7785Q46919743-98C24600-8E2C-4E26-8464-4FCCE3F47B20Q47404520-E1DA89A7-2CCD-4430-AAB9-3C3CE2E8B66FQ54038647-111D3731-A00A-4CE9-ADE3-198C24558D5C
P2860
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@en
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@nl
type
label
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@en
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@nl
prefLabel
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@en
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@nl
P2860
P356
P1476
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
@en
P2093
Nagarajan R
P2860
P304
P356
10.1128/AAC.35.4.605
P407
P577
1991-04-01T00:00:00Z